For the Inventor, By the Inventor

Enter assignee name

Marlborough, MA, United States of America

Sepracor, Inc.

USPTO Granted Patents = 322

% Expired Patents = 13.7

CIPO Patents = 20

EPO Patents = 8

Trademarks = 6

Forward Citations = 4,197

Loading Chart...

Loading Chart...

126 inventors (with patents filed for the assignee):

James W Young (47 out of 50 patents)

Thomas P Jerussi (40 out of 53 patents)

Paul D Rubin (33 out of 36 patents)

4. Chris Hugh Senanayake (32 out of 77 patents)

5. James R Hauske (32 out of 32 patents)

6. John R McCullough (32 out of 32 patents)

7. Timothy J Barberich (30 out of 32 patents)

8. Qun Kevin Fang (24 out of 37 patents)

9. Gregory D Cuny (24 out of 69 patents)

10. Charles M Zepp (23 out of 57 patents)

11. Yun Gao (20 out of 40 patents)

12. Nancy M Gray (20 out of 21 patents)

13. Brian M Aquila (19 out of 28 patents)

14. Chrisantha Hugh Senanayake (19 out of 24 patents)

15. William E Yelle (18 out of 18 patents)

Core Competencies:

CNS Disorders

D-Amino Acid Oxidase

Piperidine Ligands

Anxiolytics

Migraine Treatment

Pulmonary Disorders

Stereoselective Synthesis

Pain Management

Neurotransmitter Receptors

Heterocyclic Compounds

Optically Active Derivatives

Sibutramine Metabolites

322 patents: Sort by Forward Citations

1. 7902252 - Inhibitors of D-amino acid oxidase (2011-03-08),

2. 7893098 - Pyrrole and pyrazole DAAO inhibitors (2011-02-22),

3. 7884124 - Fluoro-substituted inhibitors of D-amino acid oxidase (2011-02-08),

4. 7816375 - Ligands for monoamine receptors and transporters, and methods of use thereof (2010-10-19),

5. 7812035 - 4-substituted piperidines, and methods of use thereof (2010-10-12),

6. 7790772 - [object Object] (2010-09-07),

7. 7776858 - Methods of treatment of chronic pain using eszopiclone (2010-08-17),

8. 7732641 - Formoterol tartrate process and polymorph (2010-06-08),

9. 7723324 - Imidazo[1,2-A]pyridine anxiolytics (2010-05-25),

10. 7718822 - Carbamate Stereoisomer (2010-05-18),

11. 7714023 - Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites (2010-05-11),

12. 7692019 - Methods for the stereoselective synthesis of substituted piperidines (2010-04-06),

13. 7671087 - Amines that inhibit a mammalian anandamide transporter, and methods of use thereof (2010-03-02),

14. 7615572 - Pyrrole and pyrazole DAAO inhibitors (2009-11-10),

15. 7589237 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2009-09-15),

Sepracor, Inc. is a pharmaceutical company that specializes in the discovery, development, and commercialization of prescription drugs. With a focus on respiratory and central nervous system disorders, Sepracor aims to improve patient outcomes and quality of life. They have a diverse portfolio of products targeting various therapeutic areas and employ advanced research techniques to drive innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

322 Patents

#5 in Marlborough, MA

#77 in Massachusetts

#1,370 in US

#2,793 in the World

Marlborough, MA, United States of America

Sepracor, Inc.

Forward Citations = 4,197

126 inventors:

James W Young (47 out of 50 patents)

Thomas P Jerussi (40 out of 53 patents)

Paul D Rubin (33 out of 36 patents)

4. Chris Hugh Senanayake (32 out of 77 patents)

5. James R Hauske (32 out of 32 patents)

Please report any incorrect information to [email protected]

Loading…